Roche Receives the US FDA's EUA for cobas SARS-CoV-2 Test to Suspect COVID-19
Shots:
- Roche’s cobas SARS-CoV-2 test to be use on high-throughput cobas 6800/8800 systems has received the US FDA’s EUA for testing individuals without symptoms or reasons to control the spread of COVID-19
- The authorization expands SARS-CoV-2 testing to include people without symptoms and applies to pooled samples containing up to and including 6 individual samples
- Asymptomatic testing with the cobas SARS-CoV-2 test is available in countries accepting the CE mark
Ref: PR Newswire | Image: Roche
Click here to read the full press release
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com